Quantum Machine Learning Framework for Virtual Screening in Drug Discovery: a Prospective Quantum Advantage
Machine Learning (ML) for Ligand Based Virtual Screening (LB-VS) is an important in-silico tool for discovering new drugs in a faster and cost-effective manner, especially for emerging diseases such as COVID-19. In this paper, we propose a general-purpose framework combining a classical Support Vector Classifier (SVC) algorithm with quantum kernel estimation for LB-VS on real-world databases, and we argue in favor of its prospective quantum advantage. Indeed, we heuristically prove that our quantum integrated workflow can, at least in some relevant instances, provide a tangible advantage compared to state-of-art classical algorithms operating on the same datasets, showing strong dependence on target and features selection method. Finally, we test our algorithm on IBM Quantum processors using ADRB2 and COVID-19 datasets, showing that hardware simulations provide results in line with the predicted performances and can surpass classical equivalents.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoveryQuantum Machine LearningSimilar Papers 제목 키워드 기반
Excited state, non-adiabatic dynamics of large photoswitchable molecules using a chemically transferable machine learning potential
Light-induced chemical processes are ubiquitous in nature and have widespread technological applications. For example, photoisomerization can allow a drug with a photo-switchable scaffold such as azobenzene to be activat…
Docking-based Virtual Screening with Multi-Task Learning
Machine learning shows great potential in virtual screening for drug discovery. Current efforts on accelerating docking-based virtual screening do not consider using existing data of other previously developed targets. T…
BIG-bench Machine LearningDrug DiscoveryMulti-Task LearningRecent Developments in Structure-Based Virtual Screening Approaches
Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year…
Drug DiscoveryDrugCLIP: Contrasive Protein-Molecule Representation Learning for Virtual Screening
Virtual screening, which identifies potential drugs from vast compound databases to bind with a particular protein pocket, is a critical step in AI-assisted drug discovery. Traditional docking methods are highly time-con…
DrugCLIP: Contrastive Protein-Molecule Representation Learning for Virtual Screening
Virtual screening, which identifies potential drugs from vast compound databases to bind with a particular protein pocket, is a critical step in AI-assisted drug discovery. Traditional docking methods are highly time-con…
Contrastive LearningData AugmentationDrug DiscoveryRepresentation Learning+1